Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Gout · Asthma

Sunshine Guojian Pharmaceutical

Sunshine Guojian Pharmaceutical (Shanghai) Co.,

Sunshine Guojian Pharmaceutical clinical programs — 27 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

FORT LAUDERDALE, FL, CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
FORT LAUDERDALE, FL, CN
Programs
165
Drugs
80
Patents
121
All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Sunshine Guojian Pharmaceutical projects

27 ClinicalTrials.gov programs sponsored by Sunshine Guojian Pharmaceutical.

Sunshine Guojian Pharmaceutical has 27 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

27 programs

Clinical programs

  1. 1% Clascoterone Cream

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acne Vulgaris

    phase 3 small molecule active

    1 trial

  2. 5% minoxidil foam

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Androgenetic Alopecia

    phase 3 small molecule active

    1 trial

  3. 601 1.25mg

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Branch Retinal Vein Occlusion

    phase 3 small molecule completed

    2 trials

  4. 608

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Axial Spondyloarthritis, Non-Radiographic

    phase 3 small molecule active

    1 trial

  5. 608 Q2W

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Plaque Psoriasis Patients

    phase 3 small molecule active

    1 trial

  6. 608 Q2W

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Psoriasis

    phase 3 small molecule completed

    1 trial

  7. 608 dose

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Ankylosing Spondylitis

    phase 3 small molecule active

    1 trial

  8. 610

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Asthma

    phase 3 small molecule active

    2 trials

  9. 611

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Sinusitis

    phase 3 small molecule active

    2 trials

  10. 611

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Dermatitis, Atopic

    phase 3 small molecule active

    3 trials

  11. 611

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Pulmonary Disease, Chronic Obstructive (COPD)

    phase 3 small molecule active

    1 trial

  12. Clascoterone

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acne Vulgaris

    phase 3 small molecule active

    1 trial

  13. Clifutinib

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Leukemia, Acute Myeloid (AML)

    phase 3 small molecule active

    1 trial

  14. EPREX®

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Renal Anemia

    phase 3 small molecule completed

    1 trial

  15. Etanercept

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Rheumatoid Arthritis

    phase 3 small molecule active

    1 trial

  16. HEC585

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Idiopathic Pulmonary Fibrosis (IPF)

    phase 3 small molecule active

    1 trial

  17. HEC74647PA+HEC110114

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic HCV Infection

    phase 3 small molecule completed

    1 trial

  18. Human Erythropoiesis Injection (CHO cell)

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Kidney Failure, Chronic

    phase 3 small molecule active

    1 trial

  19. Insulin Degludec and Insulin Aspart

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Diabetes

    phase 3 small molecule completed

    1 trial

  20. Lerotinib

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Esophageal Cancer

    phase 3 small molecule active

    1 trial

  21. Mitizodone Phosphate tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Depressive Disorder, Major

    phase 3 small molecule active

    1 trial

  22. Nalfurafine Hydrochloride

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Uremic Pruritus

    phase 3 small molecule active

    1 trial

  23. Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection 200 mg

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acute Gout

    phase 3 small molecule active

    2 trials

  24. SOF

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic HCV Infection

    phase 3 small molecule completed

    2 trials

  25. SSGJ-707

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  26. prefilled liquid etanercept(Yisaipu)

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Ankylosing Spondylitis

    phase 3 small molecule completed

    1 trial

  27. rhTPO

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Thrombocytopenia

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Sunshine Guojian Pharmaceutical have?

27 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.